Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (1616)	6/5/2003 1:25:02 PM
From: software salesperson	of 3044

from 1/03 conf. call notes: 13. restructuring charges? - - facilities consolidation; some research people will be leaving; other development/commercialization people will be hired ; headcount flat in 2003 so today's announcement takes the trimming many steps further (though it's hard to know the split between collaborative vs. non-collaborative research) it's important to raise the issue of how the future pipeline will be affected which, btw, no one in the analyst community has done recently. the last guidance given (4/02) was for 5+ nmes per year after 2004. while the number of nmes will surely drop, i believe that mlnm's research and genomics expertise will be needed more, not less, in order to figure out who will benefit as personalized medicine becomes a reality. furthermore, i believe that this expertise will be desirable to a future oncology partner. after all, it's always struck me that, in terms of respect given to mlnm , the order has been (i) pharma , (ii) si biotech community and, lastly, (iii) the analyst community sales

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next